Integra announced that it will suspend the enrollment of new patients in the clinical trial for DuraGen Plus® Adhesion Barrier Matrix for evaluating the safety and effectiveness as an adhesion barrier in spinal surgery.
SEC Filing… http://ow.ly/DcPs...
Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
